tirzepatide trial Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT Tirzepatide monotherapy in Chinese patients

Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF

With increased focus on disease management and preventive healthcare, the market is expected to observe steady growth in the coming years

Will Semaglutide interfere with my thyroid hormone replacement

Some specialists recommend evaluating the gallbladder before starting treatment, particularly in patients who may already have stones

Researchers investigating energy balance, hormonal response, and long-term metabolic adaptation may find Semaglutide a key candidate for advanced studies in metabolic regulation and peptide-based therapies